PhD Terry Cheuk-Fung Yip, MD Chung-Yan Lui, BSc Mandy Sze-Man Lai, MD Wai-Sun Wong, MPhil Yee-Kit Tse, Hon-Ming Bosco, MD Ma, MD Elsie Hui, MFM Maria Kw Leung, Henry Lik-Yuen, MD Chan, MD Shu-Cheong Hui, Lai-Hung Grace, MBChB Wong
Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients
References
Ahmad, Batool, Ain, Kim, Choi, Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations, Int J Mol Sci
Balint, Voros-Horvath, Szechenyi, Omicron: increased transmissibility and decreased pathogenicity, Signal Transduct Target Ther
Bernal, Da Silva, Musungaie, Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients, N Engl J Med
Bhimraj, Morgan, Shumaker, Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19, Clin Infect Dis
Bloomberg, Hong Kong's Nursing Homes Are Unvaccinated Hotbeds of Covid
Cheung, Fung, Chow, Tung, Structured data entry of clinical information for documentation and data collection, Stud Health Technol Inform
Consortium, Whost, Pan, Peto, Repurposed Antiviral Drugs for Covid-19 -Interim WHO Solidarity Trial Results, N Engl J Med
Dal-Re, Becker, Bottieau, Holm, Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach, Lancet Infect Dis
De Anda, Johnson, Pedley, Molnupiravir for Covid-19 in Nonhospitalized Patients. Reply, N Engl J Med
Gandhi, Malani, Rio, COVID-19 Therapeutics for Nonhospitalized Patients, JAMA
Hammond, Leister-Tebbe, Gardner, Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19, N Engl J Med
Hksar Government, Overall first-dose COVID-19 vaccination rate of RCHEs and RCHDs rises to 84 per cent on 11
Hui, Zumla, Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019, Curr Opin Pulm Med
Jo, Kim, Radnaabaatar, Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea, Epidemiol Health
Kabinger, Stiller, Schmitzova, Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis, Nat Struct Mol Biol
Krammer, SARS-CoV-2 vaccines in development, Nature
Lui, Yip, Wong, Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study, Clin Infect Dis
Najjar-Debbiny, Gronich, Weber, Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients, Clin Infect Dis
Pfizer, Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR
Roth, Emmons-Bell, Alger, Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic, JAMA Netw Open
Saravolatz, Depcinski, Sharma, Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs, Clin Infect Dis
Thorlund, Sheldrick, Meyerowitz-Katz, Singh, Hill, Making Statistical Sense of the Molnupiravir MOVe-OUT Clinical Trial, Am J Trop Med Hyg
Vangeel, Chiu, Jonghe, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern, Antiviral Res
Wong, Au, Lau, Lau, Cowling et al., community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational study,
doi:10.1101/2022.05.26.22275631
Yip, Wong, Lui, Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19, Hepatology